GLOSTRUP, DENMARK--(Marketwire - April 07, 2011) - Egil Mølsted Madsen is appointed new CFO of Dako A/S and Dako Denmark.
As of May 9, 2011, Egil Mølsted Madsen takes over the position of Chief Financial Officer (CFO) of Dako A/S and Dako Denmark, a worldwide provider of cancer diagnostics solutions.
"Dako has just released its 2010 results. The best results ever in the company's history. However, our company holds even higher potential with our high- quality products and our strategy of fighting cancer by delivering the highest standards and accuracy in cancer diagnostics to the pathology laboratories. Egil Mølsted Madsen will play an important role for Dako in accelerating this strategy further, and I am pleased to welcome Egil, who is already an experienced executive with a strong track record as CFO," says Lars Holmkvist, CEO at Dako.
Egil Mølsted Madsen brings over 20 years of experience in finance and accountancy to Dako, including experience from CFO positions in two divisions in his prior company.
About Dako Dako is based in Denmark and is a global leader in tissue-based cancer diagnostics. Hospitals and research laboratories worldwide use Dako's know- how, reagents, instruments and software to make precise diagnoses and determine the most effective treatment for patients suffering from cancer. Employing more than 1000 persons and operating in more than 80 countries, Dako covers essentially all of the global anatomic pathology markets. Dako is owned by a private equity fund, EQT.www.dako.com
Curriculum Vitae Egil Mølsted Madsen :
http://hugin.info/136715/R/1504054/438935.pdf
This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Dako Denmark A/S via Thomson Reuters ONE
[HUG#1504054]
